Stryker's OP-I implant nears Australian approval:
This article was originally published in Clinica
Executive Summary
The Australian Drug Evaluation Committee has recommended that Stryker's OP-1 Implant be approved for the treatment of non-union long bone fractures secondary to trauma. The implant, licensed from Curis, has already received a similar recommendation in Europe, although the US FDA recently declined to grant approval. A final decision by the Australian Therapeutic Goods Agency is expected within three months.